Stemming from foundational discoveries in Wnt pathway modulation, Biosplice has elucidated novel biology linking CLK/DYRK kinases to the therapeutic regulation of alternative splicing. Alternative splicing is an essential biological mechanism that regulates the diversification of proteins in a cell, which, in turn, determines cell type and function. Biosplice’s target class governs the selection o
f tissue-specific mRNA splice sites, making them attractive, druggable targets within the cellular “command and control” center. Biosplice’s drugs in clinical development include lorecivivint for osteoarthritis (in Phase 3), cirtuvivint for numerous cancers, and a broad pipeline that ranges from Alzheimer’s disease to other degenerative conditions. Learn more at https://www.biosplice.com
Welcome to our page. We look forward to the opportunity to engage with you and would like to share some basic ‘house rules’ to encourage everybody to get the most from the community. We work in a regulated industry and because of the unique legal situation in the healthcare space, we can't engage in sensitive topics, or discussion(s) about products - ours or other companies' - or treatment options on this page. As a result, we want to make sure that the discussions that take place on the timeline stay on topic and are constructive. If your comment doesn’t comply with the following basic rules, it may be delayed, or in some cases, not be published:
1. If your posts are product related;
2. If your posts include profane, defamatory, libelous, offensive, abusive, discriminatory or demeaning content (including images, videos and links);
3. If your posts are disparaging or threatening or condone violence or illegal behavior;
4. If your posts are off-topic;
5. If your posts offer health or medical advice;
6. If your posts contain any personal information, e.g. names of individuals, email addresses or phone numbers;
7. If your posts contain any personal health information;
8. If your posts violate another’s copyright or intellectual property;
9. If your posts are commercial, e.g. sells products and services, or recruit fans and followers;
10. If your posts are excessively repetitive and/or disruptive to the community or are spam;
11. If your posts contain proprietary, confidential, sensitive, or nonpublic information;
12. If your posts don’t follow Facebook's posting guidelines and Terms of Use. If you are a subject in one of our clinical trials, to help make sure that the data from the study is as accurate and reliable as possible, please do not discuss information about the study in public places while the study is in progress. Public places may be situations like support groups, internet messaging boards, or social media. If you are interested in any of our clinical trials, please visit www.clinicaltrials.gov and type “Biosplice” into the search bar. Please be aware that fans who continuously and repeatedly contravene the above rules may be removed from our fan list. In this case the user would no longer be able to follow our news, comment on our posts, or send us messages. This community is English speaking only and as such any non-English language content will be removed. If you believe that you have experienced any medical side effects or reactions from a Samumed product you should consult your physician. We suggest sharing as little personal information as possible on the page. In particular, sharing any specific data concerning your personal health should be avoided. Should you, however, decide to include a post detailing any side effects, Biosplice Therapeutics may need to contact you to find out more information. Posts of this nature may not appear or may need to be removed from our page; this is due to legal obligations concerning drug safety reporting. We do not aim to store or use your Facebook profile unique ID, email, or other personal details. Please note that Facebook also has access to information you share with us. For more details read the Facebook Privacy Policy. Thank you for reading and being a part of the community.
